載入...
Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
Fabry disease is a rare, X-linked, lysosomal storage disease caused by mutations in the gene encoding the enzyme alpha-galactosidase A. Complete or partial deficiency in this enzyme leads to intracellular accumulation of globotriaosylceramide (Gb(3)) and related glycosphingolipids in many cell types...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029839/ https://ncbi.nlm.nih.gov/pubmed/24886109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-72 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|